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Indian hedgehog (Ihh) controls multiple aspects of endochondral skeletal development by signaling to both chondrocytes and perichondrial
cells. Previous efforts to delineate direct effects of Ihh on chondrocytes by Col2-Cre-mediated ablation of Smoothened (Smo, encoding a
transmembrane protein indispensable for Ihh signaling) has been only partially successful, due to the inability to discriminate between chondrocytes
and perichondrial cells. Here we report a transgenic line (Col2-CreTM) expressing under the control of the Colα1(II) promoter an inert form of Cre
that is activatable by exogenous tamoxifen (TM); TM administration at proper times during embryogenesis induced Cre activity in chondrocytes but
not in the perichondrium. By using this mouse line, we deleted Smo within subsets of chondrocytes without affecting the perichondrium and found
that Smo removal led to localized disruption of the expression of parathyroid hormone-related protein (PTHrP) and the morphology of
chondrocytes. Unexpectedly, TM invariably induced Cre activity in a subset of cells associated with the trabecular bone surface of long bones.
These cells, when genetically marked and cultured in vitro, were capable of producing bone nodules. Expression of the Col2-CreTM transgene in
these cells likely reflected the endogenous Colα1(II) promoter activity as similar cells were found to express the IIA isoform of Colα1(II) mRNA
endogenously. In summary, the present study has not only provided evidence that Ihh signaling directly controls PTHrP expression and
chondrocyte morphology in the growth region cartilage, but has also uncovered a distinct cell type associated with the trabecular bone that appears
to possess osteogenic potential.
© 2007 Elsevier Inc. All rights reserved.Keywords: Ihh; Smo; PTHrP; Type IIA procollagen; Cre; Tamoxifen; Cartilage; MouseIntroduction
Much of the vertebrate skeleton arises from cartilage tem-
plates that originate from mesenchymal condensations and
eventually undergo endochondral ossification. Prior to overt
chondrocyte differentiation, the condensing mesenchyme ex-
presses the IIA splice form of type II collagen (Ng et al., 1993;
Sandell et al., 1991, 1994); subsequently cells in the core of the
condensation switch to express the IIB splice form characteristic
of chondrocytes, whereas the peripheral cells upregulate expres-
sion of type I collagen forming the perichondrium. Following⁎ Corresponding author. Department of Medicine, Washington University
School of Medicine, St. Louis, MO 63110, USA. Fax: +1 314 454 8747.
E-mail address: flong@im.wustl.edu (F. Long).
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doi:10.1016/j.ydbio.2007.05.011formation of the cartilage anlage, chondrocytes initially proli-
ferate, but progressively exit the cell cycle and undergo
hypertrophy starting at the center of the element. The hyper-
trophic cartilage is eventually removed upon the invasion of
blood vessels and replaced by bone and the marrow cavity. The
continued orderly progression of chondrocytes from prolifera-
tion to hypertrophy results in the characteristic growth plates
located at both ends of the cartilage template, where the round
chondrocytes are near the articular surface, followed by the flat
chondrocytes arranged in columns (columnar chondrocytes),
and finally the hypertrophic chondrocytes adjacent to the mar-
row cavity. The repeated process of hypertrophy and removal of
chondrocytes eventually gives rise to the final form of an
endochondral bone in which much of the cartilage is replaced by
bone. Thus, proper formation of an endochondral bone requires
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tion, vascular invasion as well as osteoblast differentiation.
Indian hedgehog (Ihh) critically controls multiple aspects of
the development of endochondral bones. In the developing car-
tilage, Ihh is produced by prehypertrophic (immediately before
hypertrophic) as well as early hypertrophic chondrocytes, and it
signals to both the immature chondrocytes and the overlying
perichondrial cells (St-Jacques et al., 1999; Vortkamp et al.,
1996). Ihh homozygous null mutant mice exhibited a marked
reduction in chondrocyte proliferation, profound dysregulation
of chondrocyte maturation, a severe defect in cartilage vascul-
arization as well as a complete lack of osteoblasts (Long et al.,
2001; St-Jacques et al., 1999). More recently, genetic experi-
ments have implicated Ihh in positively regulating the length of
the columnar region as ectopic Ihh expression induced by mos-
aic ablation of parathyroid hormone-related protein receptor
(PTHrP-R) in the growth plate lengthened the columnar region
(Kobayashi et al., 2005). On the other hand, Col2-Cre-mediated
removal of Smoothened (Smo), which encodes a transmembrane
protein indispensable for all Hh signaling (Alcedo et al., 1996;
van den Heuvel and Ingham, 1996; Zhang et al., 2001),
abolished the same region within the growth plate (Long et al.,
2006).
Genetic manipulation of Smo in the mouse has revealed that
Ihh functions via either direct or indirect signaling on target cells.
For instance, direct Ihh input was required for proper proli-
feration of chondrocytes as well as development of the osteo-
blast lineage (Long et al., 2001, 2004), whereas regulation of
chondrocyte maturation appeared to be mediated primarily via a
secondary signal, parathyroid hormone-related protein (PTHrP)
(Karp et al., 2000; Long et al., 2001). Although PTHrP ex-
pression in the periarticular cartilage is known to depend upon
Ihh signaling (St-Jacques et al., 1999), which most likely func-
tions by antagonizing Gli3 repressor activity (Hilton et al., 2005;
Koziel et al., 2005), it is not clear whether direct Ihh input in the
periarticular chondrocytes is required for this regulation. Indeed,
although earlier work suggested that Ihh may indirectly regulate
PTHrP by signaling through the adjacent perichondrium (Vort-
kamp et al., 1996) via a secondary signal such as TGFβ2
(Alvarez et al., 2002), a recent report challenged this view as
exogenous TGFβ1 failed to activate PTHrP expression in the
absence of Ihh signaling in an organ culture model (Koziel et al.,
2004). Moreover, although removal of Smo using a Col2-Cre
line abolished PTHrP expression in the periarticular chondro-
cytes but not in the periarticular perichondrium (Long et al.,
2001), it could not be conclusive whether the loss of PTHrPwas
specifically due to the removal of Ihh responsiveness in chon-
drocytes as Col2-Cre was also active in at least a subset of
perichondrial cells (Long et al., 2004). For the same reason, the
loss of columnar region in the growth plate of the Col2-Cre;
Smon/c mutant embryo could not be attributed specifically to the
removal of Smo in chondrocytes (Long et al., 2006). Thus, a
clear delineation of direct effects of Ihh signaling in chondro-
cytes awaits genetic tools better distinguishing them from peri-
chondrial cells.
Compared to growth plate development, relatively little is
understood about endochondral (within the cartilage) boneformation per se. The process begins with vascular invasion of
the hypertrophic cartilage and produces the trabecular bone and
is distinct from ossification within the perichondrium that
initiates slightly earlier and contributes to the cortical bone. A
conventional view holds that the osteoblastic cells (osteoblasts
and their progenitors) at both locations differentiate and behave
similarly. On the other hand, as the trabecular versus the peri-
osteal bone cells reside in distinct microenvironment, it is
conceivable that they are regulated and maintained differently.
Recent evidence supports this view as constitutive activation of
PTHrP signaling in all osteoblasts in the mouse increased bone
formation in the trabecular but not the cortical region (Calvi et
al., 2001). However, no molecular features have been reported
to distinguish the cortical versus trabecular osteoblastic cells.
Here we report the generation of a transgenic mouse line
(Col2-CreTM) that can be used to restrict Cre activity to chon-
drocytes versus perichondrial cells upon proper administration
of tamoxifen (TM). By using the Col2-CreTM line to locally
remove Smo, we have provided evidence that Ihh likely regu-
lates PTHrP expression and chondrocyte morphology in a direct
manner. In addition, we demonstrate that the Col2-CreTM trans-
gene is expressed by a subset of cells that are associated with the
trabecular bone surface and possess osteogenic potential.Materials and methods
Mouse strains
To generate the Col2-CreTM transgene, a 2 kb cDNA encoding CreTM
(Danielian et al., 1998) was ligated into the EcoRV site of a modified form of the
Col2a1 expression vector (Horton et al., 1987). The transgene was released by
NotI and EcoRI digestion, purified and injected into the pronuclei of fertilized
eggs from CBA/BL6-F1/J females (Jackson Laboratory). Pronuclear injection
was performed by the Mouse Genetics Core (Washington University Medical
School). Founder mice and their progenies were genotyped by PCR using
primers specific for Cre.
Mice carrying Smon (Zhang et al., 2001) or Smoc (Long et al., 2001) alleles
were as previously described.
Tamoxifen (TM) administration
TM (Sigma, St. Louis) dissolved in corn oil (Sigma) was injected intra-
peritoneally into either pregnant females or postnatal pups. For the initial
screening of founders, 100 μg TM per gram of body weight was injected into
pregnant females. Dosages for other injections were as indicated in each
experiment.
Analysis of mouse embryos
Lac Z stainings were performed on either whole embryos or frozen sections.
Whole embryos were stained as previously described (Whiting et al., 1991).
Frozen sections were prepared and stained using a protocol based on a published
procedure (Lobe et al., 1999). The sections were counterstained with nuclear fast
red.
For histology and in situ hybridization, limbs were prepared and sectioned
as described previously (Hilton et al., 2005; Long et al., 2001). The in situ
probe for Colα1(II)A was generously provided by Dr. Linda Sandell
(Washington University Medical School) (Zhu et al., 1999). All other in situ
hybridization probes were as previously described (Hilton et al., 2005; Long et
al., 2001).
For co-localization studies, frozen sections were first stained for Lac Z
activity and then subjected to in situ hybridization using 35S-labeled riboprobes.
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nuclear fast red.
Bone marrow stromal cell cultures
Bone marrow stromal cells were isolated from the femur and the tibia of
2-month-old mice at 12 h after TM administration via oral gavage at 125 μg per
gram of body weight. Briefly, upon surgical removal of the epiphyseal ends, the
bone shafts were flushed with α-MEM with a 25-gauge needle. Cells from a
single mouse were centrifuged, treated with the red blood cell lysis buffer
(Roche), rinsed and resuspended in α-MEM containing 20% fetal bovine serum,
before being filtered through a 70 μm cell strainer (Falcon) and plated at 2×106/
well in 12-well plates. Half of the medium was changed at day 3 and all medium
changed at day 6 of culture to remove floating cells. Multiple cultures were
performed in parallel for each animal to allow Lac Z staining at different time
points. For bone nodule assays, cells cultured to confluence were switched to
mineralization medium containing ascorbic acid and β-glycerophosphate and
further cultured for 10 days. For Lac Z staining, the cultures were fixed for 5 min
before proceeding with the protocol (Lobe et al., 1999). For von Kossa staining,
cultures previously subjected to Lac Z staining were incubated with 1% silver
nitrate under bright light and finally washed with PBS.
Results
Generation of a Col2-CreTM transgenic mouse line
To generate genetic tools expressing Cre specifically in
chondrocytes but not in perichondrial cells, we sought to bypass
the transient Colα1(II) promoter activity present in the pre-
cursors of perichondrial cells. To this end, we took advantage of
a modified form of Cre (CreTM) in which the recombinase was
fused to a mutated ligand binding domain of the estrogen
receptor and rendered inactive but activatable by exogenous TM
(Danielian et al., 1998). Specifically, we established transgenic
mice (Col2-CreTM) by injecting DNA expressing CreTM under
the Colα1(II) promoter/enhancer (Fig. 1A) into the pronuclei of
fertilized eggs. Fifteen male founder mice carrying the trans-
gene were obtained and screened by crossing with the Rosa26
reporter (R26R) mouse, which expresses β-galactosidase spe-
cifically in cells that presently or previously express Cre activity
(Soriano, 1999). Embryos were harvested at E12.5 without
exposure to TM and those carrying the genotype ofCol2-CreTM;
R26R were assayed for “leaky” Cre activity. Through this
procedure, 6 founders were found to express at least some level
of Cre activity without TM induction and were therefore
eliminated from further analyses. The remaining 9 founders
were again crossed with R26R females, which this time received
intraperitoneal injections of TM at E10.5; embryos were har-
vested at E12.5 and assayed for β-galactosidase activity. Two
founders that exhibited the most robust TM-dependent
β-galactosidase activity were selected for further analyses.
Since the two lines behaved identically in all assays, here we
only report results obtained from one such line.
Temporal control of Cre activity
To assess the onset of the transgene expression during
embryogenesis, we generated Col2-CreTM; R26R embryos that
were induced with TM at progressively earlier time points and
harvested at E12.5 to assay for β-galactosidase activity. Withinjection at E10.5, we detected Cre activity in all cartilage
throughout the embryo (Fig. 1C). In particular, both forelimbs
and hindlimbs expressed robust activities in all skeletal ele-
ments (Figs. 1C1 and C2, respectively). However, when TM
was administered at E9.5, in the limb, only the elements
including and proximal to the zeugopod exhibited Cre ac-
tivity, whereas the autopod had little or no activity (Figs. 1B1
and B2). Earlier injections up to E6.5 produced a similar Lac
Z staining pattern to the E9.5 injection (data not shown). In
all cases, Col2-CreTM; R26R embryos not induced with TM
showed no β-galactosidase activity (data not shown). Thus,
expression of the Col2-CreTM transgene in principle tracks
the proximal-to-distal progression of chondrogenesis in the
limb.
We next examined whether proper timing of TM adminis-
tration during embryogenesis could restrict Cre activity to
chondrocytes without inducing a significant level in the
perichondrium. For consistency we have focused the analyses
on the humerus. As preliminary analyses of the embryos
induced at E10.5 had revealed Cre activity in both chondrocytes
and perichondrial cells (data not shown), we next examined
Col2-CreTM; R26R embryos exposed to TM at E11.5, E12.5,
E13.5 or E14.5 and harvested at E17.5. With E11.5 injection,
the proximal half of the humerus showed robust Cre activity in
the chondrocytes (red arrow) in contrast to a minor level in the
perichondrium (green arrowhead) (Fig. 2A1), but the distal half
still exhibited strong activities in both chondrocytes (red arrow)
and the perichondrium (green arrowhead) (Fig. 2A2). In
addition, Cre activity was also evident in the primary spongiosa
(purple arrow, Fig. 2A1) and within the elbow joint capsule
(asterisk, Fig. 2A2). On the other hand, when TM was ad-
ministered at E12.5, the proximal half showed no detectable Cre
activity in the perichondrium (green arrowhead) despite robust
levels in chondrocytes (red arrow) (Fig. 2B1). Within the distal
half, Cre activity in both the perichondrium (green arrowhead)
and the elbow joint region (asterisk) was markedly reduced
(Fig. 2B2). However, clear Cre activity remained within the
primary spongiosa (purple arrow, Fig. 2B1) (discussed below).
Similar results were obtained with TM injection at E13.5 (Figs.
2C, C1, C2) or E14.5 (Figs. 2D, D1, D2), but Cre activity in the
distal perichondrium was further reduced. Interestingly, a small
number of the distal perichondrial cells remained positive even
with the later injections; reasons for the discrepancy between
distal and proximal perichondrium are not known but may be
unique to the humerus as a similar difference was not evident in
the radius or the ulna (Fig. S1). On the other hand, the prog-
ressive restriction of Cre activity to chondrocytes and the
primary spongiosa was confirmed in other long bones including
the radius and the ulna (Fig. S1). Thus, TM administration at or
after E12.5 restricted Cre largely to chondrocytes and the
primary spongiosa in long bones.
We next assessed whether the Col2-CreTM line could be
useful for postnatal gene removal. To this end, Col2-CreTM;
R26R animals were injected TM at postnatal day 12 (P12) and
14 (P14) and then harvested at P16 for Lac Z staining. Strong
signals were observed in a large number of chondrocytes at the
proximal end of the humerus (Fig. 3A). In particular, nearly
Fig. 1. Tamoxifen (TM) inducible Col2-CreTM transgenic mouse. (A) Schematic of the Col2-CreTM transgene. G.S.S., β-globin splicing sequence. ERTM, modified
form of the estrogen receptor responsive only to exogenous tamoxifen. (B, C) β-galactosidase activity assays (Lac Z staining) indicating induction of Cre by TM in
Col2-CreTM; R26R embryos. Whole embryos were stained at E12.5 after pregnant females were injected with 75 μg/g TM (75 μg TM per gram of body weight) at
either E9.5 (B) or E10.5 (C). Forelimbs (FL) (B1–C1) and hindlimbs (HL) (B2–C2) were shown at a higher magnification beneath the corresponding whole embryos.
a: autopod, z: zeugopod, s: stylopod, sc: scapula.
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activity (Fig. 3A2). Similarly, a high percentage of the articular
chondrocytes exhibited strong activities (Fig. 3A3). In addition,
Cre activity was induced within both primary (Fig. 3A1) and
secondary (“2°”, Fig. 3A) ossification centers. In contrast, TM
injection in animals carrying Col2-CreTM but not the R26R
allele did not induce any β-galactosidase activity in any
chondrocytes (Figs. 3B–B3). Similarly, in the absence of TM
animals with the genotype Col2-CreTM; R26R did not show any
activity in chondrocytes (data not shown). However, the control
animals showed a weak β-galactosidase-like activity within
both primary and secondary ossification centers (Figs. 3B and
B1). The activity, judged by the intensity of Lac Z staining, was
noticeably weaker than that induced by TM and appeared to be
transient because it was not detected either in embryonic bonesor in 2-month-old animals (see below). Overall, successful gene
deletion can be achieved in the postnatal cartilage using the
Col2-CreTM transgenic line.
Expression of Col2-CreTM in trabecular bone surface cells
The persistent TM-inducible β-galactosidase activity within
the ossification centers of Col2-CreTM; R26R animals prompted
us to examine whether bone-associated cells expressed the
Col2-CreTM transgene. To confirm that the Lac Z-positive cells
in the primary spongiosa were not derived from Lac Z-positive
perichondrial cells, we administered TM to Col2-CreTM; R26R
embryos at E13.5 to minimize Cre activity in the perichon-
drium. As expected, when the embryos were assayed at E17.5,
virtually no perichondrial cell within the proximal half of the
Fig. 2. Control of cell-type specific Cre activity in the embryo. Lac Z staining was performed on cryostat longitudinal sections of the humerus from E17.5 Col2-CreTM;
R26R embryos. The embryos were harvested after pregnant females were injected with 25 μg/g TM (25 μg TM per gram of body weight) at E11.5 (A), E12.5 (B),
E13.5 (C) or E14.5 (D). Green and red boxes in panels A–D identify areas that are shown below at a higher magnification. The proximal end is to the left in all panels.
Red arrows: activity in chondrocytes; purple arrows: activity in primary spongiosa; black arrow: chondrocytes of deltoid tuberocity; green arrowheads: perichondrium;
asterisks: activity around joint capsule.
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4A, B). However, robust Lac Z staining was detected in the
primary spongiosa (purple arrow, Figs. 4A, B). At a higher
magnification, most Lac Z-positive cells appeared to adhere to
the surface of the trabecular bone (green contour), assuming
either flat (red arrow) or cuboidal (green arrow) morphology
(Fig. 4A1), whereas some others appeared to be osteocytes
embedded within the bone matrix (blue arrows, Fig. 4B1).
Thus, in Col2-CreTM; R26R embryos, TM induced Cre activity
in trabecular bone-associated cells, independent of the activity
in the perichondrium.To exclude the possibility that the Lac Z-positive cells in the
primary spongiosa were progenies of chondrocytes that pre-
viously expressed Cre, we minimized the time between TM
injection and embryo harvest. TM injection 6 h prior to the
harvest at E17.5 induced Cre in a small number of immature
chondrocytes (red arrow) and very few hypertrophic cells (“H”)
in Col2-CreTM; R26R embryos (Fig. 4C). However, a
significant number of Lac Z-positive cells were detected within
the primary spongiosa (purple arrow, Fig. 4C). Consistent with
the earlier observation, most positive cells appeared to associate
with the trabecular bone surface (green contour), exhibiting
Fig. 3. Induction of Cre activity in postnatal mice. (A, B) Lac Z staining on cryostat longitudinal sections through the proximal end of the humerus from P16 animals.
Mice with the genotype of either Col2-CreTM; R26R (A) or Col2-CreTM (B) were injected 400 μg/g TM (400 μg TM per gram of body weight) at P12 and P14. Color-
coded rectangular boxes in panels A and B identify areas shown at a higher magnification below (A1–A3 and B1–B3 respectively). The proximal end is to the top in
all panels. 2°: secondary ossification center.
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(Fig. 4C1). However, no Lac Z-positive osteocytes were
noticed in these samples (Fig. 4C1, and data not shown),
indicating that the positive osteocytes observed earlier were
probably progenies of the positive cells on bone surfaces. As a
control, a littermate embryo carrying R26R but no Col2-CreTM
did not show any activity in any cells (Figs. 4D, D1).
Furthermore, TM injection 3 h prior to the harvest also induced
Cre activity in trabecular bone surface cells of Col2-CreTM;
R26R embryos (data not shown). Finally, Cre activity in these
cells was confirmed in a second Col2-CreTM transgenic line
(Fig. S2). Thus, in Col2-CreTM; R26R embryos, a pool of
trabecular bone surface cells appears to actively express the
transgene.
To examine whether expression of the Col2-CreTM transgene
associated with the trabecular bone reflects endogenous activity
of the Colα1(II) promoter, we performed in situ hybridization
for Colα1(II) mRNA on sections of developing long bones. In
E18.5 embryos, a conventional probe that recognized both the
IIA and the IIB form revealed a consistent but relatively weak
signal in the trabecular osteoblastic cells, compared to the
overwhelming levels in the growth plate chondrocytes (data not
shown). On the other hand, a probe exclusively against exon 2
and therefore specific for the IIA splice form detected a mar-
kedly stronger signal in the primary spongiosa (green arrow)than in chondrocytes (asterisk), both in the tibia (Fig. 5A) and in
the humerus (data not shown). In addition, Colα1(II)Awas also
detected on the endosteal surface (black arrow) of the cortical
bone, with little, if any, expression on the periosteal surface
(purple arrow) (Fig. 5A). Similar to the Lac Z-positive cells in
Col2-CreTM; R26R embryos, the Colα1(II)A-positive cells
(red arrow, Fig. 5A1) represented a subset of cells associated
with the trabecular bone surface whereas the others (blue arrow,
Fig. 5A1) did not show any expression. Thus, expression of the
Col2-CreTM transgene in the trabecular bone surface cells likely
reflects the endogenous Colα1(II) promoter activity in those
cells.
To explore the molecular identity of the Col2-CreTM-
expressing bone surface cells, we examined the expression of
Colα1(I) and bone sialoprotein (Bsp), two known osteoblast
markers. Specifically, sections from E17.5 Col2-CreTM; R26R
embryos induced with TM for 6 h were first stained for Lac Z
activity and then subjected to in situ hybridization. As expected,
both Colα1(I) and Bsp were expressed at high levels in the
primary spongiosa (Figs. 5B, C). However, at a higher magni-
fication, it appeared that no Lac Z-positive cells expressed high
levels of either osteoblast marker (Figs. 5B1, C1). Thus, the
Col2-CreTM-positive cells associated with the trabecular bone
surface appear to be distinct from the cells expressing high
levels of Colα1(I) or Bsp.
Fig. 4. Cre activity in trabecular osteoblast lineage cells. Lac Z staining on cryostat longitudinal sections through the humerus from E17.5 embryos with the indicated
genotypes. The pregnant females were injected with 25 μg/g TM (25 μg TM per gram of body weight) at either E13.5 (A, B) or 6 h prior to harvest (C, D). The proximal
half of the humerus is shown in panels A–D.Red boxes in panels A–D indicate areas shown at a highermagnification (A1–D1, respectively). Red arrows in panels A–C:
activity in chondrocytes; purple arrows in panels A–C: activity in primary spongiosa; green arrowheads in panels A and B: perichondrium; red arrows in panels A1 and
C1: Lac Z-positive flat cells; green arrows in panels A1 andC1: Lac Z-positive cuboidal cells; black arrows in panels A1, C1 andD1: Lac Z-negative cells; blue arrows in
panel B1: Lac Z-positive osteocytes; green contours in panels A1–D1: outlines of bone surface; H: hypertrophic zone. The proximal end is to the left in all panels.
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The finding that the Col2-CreTM-expressing cells associate
with the bone surface but lack high-level Colα1(I) or Bsp
expression prompted us to investigate whether they could be
precursors for osteoblasts. To this end, we administered TM at2 months of age and harvested the animals after 12 h. With one
hindlimb of each animal, we performed Lac Z staining on
sections and confirmed that acute TM treatment induced Lac
Z-positive cells on trabecular bone surfaces in the Col2-CreTM;
R26R animals (arrows, Fig. 6A′) but not in the Col2-CreTM
controls (Fig. 6B). With the other hindlimb, we isolated and
Fig. 5. Expression of Colα1(II)A by trabecular osteoblast lineage cells. (A) In situ hybridization using 35S-labeled riboprobe specific to (II)A on longitudinal sections
through the tibia of E18.5 wild type embryos. Signal is in red and counterstain in blue. Black arrow in panel A: endosteal surface of cortical bone; purple arrow in panel A:
periosteal surface of cortical bone; asterisk in panel A: signal in chondrocytes; green arrows in panel A: primary spongiosa; blue arrow in panel A1: cell without signal;
red arrow in panel A1: cell with signal. (B, C) Lac Z staining followed by in situ hybridization on frozen sections through the humerus of E17.5 Col2-CreTM; R26R
embryos induced with 25 μg/g TM for 6 h. Lac Z signal in blue, in situ signal in red, counterstain in magenta. Note that bone trabeculae were not stained. Also note that
black arrows in panels B and C point to dark specks representing oversaturated in situ signal not Lac Z staining. Red arrows in panels B1 and C1: Lac Z-positive cells;
green arrows in panels B1 and C1: high-expressers of Bsp orColα1(I). The proximal end is to the left in all panels. Boxed regions are shown at a higher magnification to
the right (A1–C1). “PH”: prehypertrophic chondrocytes; “H”: hypertrophic chondrocytes.
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Lac Z staining of sub-confluent cultures consistently identified
positive cells in the Col2-CreTM; R26R samples (Fig. 6C) but
not in the controls (Fig. 6D). Importantly, when confluent
stromal cells were further cultured in mineralization media to
induce osteoblast differentiation, followed by Lac Z and von
Kossa staining, certain von Kossa-positive bone nodules in the
Col2-CreTM; R26R cultures were found to consist predomi-
nantly of Lac Z-positive cells (Figs. 6E–E′), whereas the controlcultures, as expected, did not have any positive cells (Figs. 6F–
F′). Thus, Col2-CreTM-positive cells isolated from the bone
marrow can differentiate in vitro to produce mineralized matrix,
a hallmark of osteoblasts.
TM dose dependence of Cre activity
To explore the potential utility of the Colα1(II)-CreTM line
in gene removal within subsets of chondrocytes, we exa-
Fig. 6. Osteogenic potential of Col2-CreTM-positive cells isolated from the bone marrow. Two-month-old mice were analyzed at 12 h after TM delivery via oral gavage
at 125 μg per gram of body weight. (A) Lac Z staining on a longitudinal section through the tibia of a Col2-CreTM; R26R mouse. Black arrow denotes Lac Z-positive
chondrocytes. (A′) The boxed area in panel Aviewed at a higher magnification. Red arrows denote Lac Z-positive cells on trabecular bone surfaces. (B) An equivalent
region from a Col2-CreTM mouse containing no Lac Z-positive cells. (C, D) Lac Z staining of sub-confluent cultures of bone marrow stromal cells isolated from Col2-
CreTM; R26R (C) versus Col2-CreTM (D) animals. (E, F) Lac Z staining of bone nodules from Col2-CreTM; R26R (E) or Col2-CreTM (F) cultures. Purple arrow denotes
a bone nodule which consists predominantly of Lac Z-positive cells; purple arrowhead denotes an adjacent nodule with no Lac Z-positive cells. (E′–F′) von Kossa
staining of the same bone nodules following Lac Z staining in panels E, F.
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bryos were administered varying amounts of TM at E16.5
and assayed for Cre activity at E17.5. A direct correlation
was observed between the TM dosage and the percentage of
chondrocytes expressing β-galactosidase in Col2-CreTM;
R26R embryos. In particular, whereas a higher dosage in-
duced activity in nearly 80% of the growth region chondro-
cytes (Figs. 7A–A2), a lower amount of TM activated Cre in
less than 10% of the chondrocytes within the proximal half
of the humerus (Figs. 7B, B1), although a slightly higher
percentage was found within the distal growth plate (Figs. 7B,
B2). At the lower dosage, the positive cells were often found in
small clusters (red arrow) although single positive cells were
also seen at a lower rate (green arrow) (Fig. 7B1). Thus, the
amount of TM positively correlates with the percentage of
chondrocytes undergoing Cre recombination in the Col2-CreTM
mouse.Direct regulation of PTHrP expression and chondrocyte
morphology by Ihh
To examine the effects of a direct Ihh input in chondrocytes,
we genetically removed Smo from subsets of cells within the
growth region. To this end, we induced Cre recombination in
embryos of Col2-CreTM; Smon/c that carried the Col2-CreTM
transgene, one Smo null allele (Smon) and one Smo conditional
allele (Smoc). In particular, we administered an intermediate
dose of TM at E11.5 and analyzed at E14.5 the proximal growth
plate of the humerus, where Cre induction was found to be
largely restricted to chondrocytes (see Fig. 2A1). Since up-
regulation of Patched 1 (Ptch1), a direct transcriptional target of
the Hh pathway (Agren et al., 2004), requires Smo function, we
have monitored Ptch1 expression to assess the removal of Smo.
In the wild type embryo, Ptch1 was detected at high levels in
the perichondrium (green arrowheads, Fig. 8A6) flanking the
Fig. 7. TM dose dependence of Cre activity in the embryo. Lac Z staining was performed on cryostat longitudinal sections of the humerus from E17.5 Col2-CreTM;
R26R embryos. The embryos were harvested after pregnant females were injected at E16.5 with either 100 (A) or 12.5 (B) μg/g TM (100 or 12.5 μg TM per gram of
body weight). Green and red boxes in panels A and B identify areas shown below at a higher magnification (A1–A2, B1–B2, respectively). The proximal end to the
left in all panels. Red arrow: a cluster of positive cells; green arrow: a single positive cell; green arrowheads: residual activity in perichondrium.
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expressed by immature chondrocytes in a graded pattern, with
the highest level present in cells adjacent to the Ihh source (Fig.
8A6). In the TM-induced Col2-CreTM; Smon/c embryos, the
high-level expression was maintained in the perichondrium
(green arrowheads, Figs. 8B6, C6), confirming a normal res-
ponse to Ihh in this tissue. However, groups of immature chon-
drocytes were found to be devoid of Ptch1 (asterisks, Figs. 8B6,
C6), indicating effective removal of Smo in those cells. Notably,
the size and location of the affected region varied between theFig. 8. Direct regulation of PTHrP expression and chondrocyte morphology by Ihh.
C4–C7) performed on adjacent longitudinal sections of humerus from E14.5 wild t
respectively) littermate embryos. The embryos were harvested after pregnant female
proximal half of each section is shown with the articular surface to the left. The colo
panels A2–A3, B2–B3 and C2–C3, respectively. Red arrows in panels B2 and C2 de
irregular spacing between cells. 35S-labeled probes used for in situ hybridization are
Orange arrows in panels B4 and C4 denote ectopic Colα1(X) expression; color-code
adjacent sections; asterisks in panels B6 and C6 indicate areas devoid of Ptch1 exptwo Col2-CreTM; Smon/c embryos of the same litter (Fig. 8B6
vs. C6), revealing a stochastic aspect of TM-induced gene
deletion. Overall, proper administration of TM induced deletion
of Smo within subpopulations of the growth region chondro-
cytes without disrupting Ihh signaling in the perichondrium.
We next examined the effect of the local removal of Smo on
PTHrP expression. For this, in situ hybridization was performed
on adjacent sections for Ptch1 and PTHrP. At the proximal end
of the humerus of E14.5 embryos, PTHrP was normally de-
tected in a group of periarticular chondrocytes that also ex-Histology (A1–A3, B1–B3, C1–C3) and in situ hybridization (A4–A7, B4–B7,
ype (WT) (A1–A7) and Col2-CreTM; Smon/c (MT1 and MT2) (B1–B7, C1–C7
s were injected 50 μg/g TM (50 μg TM per gram of body weight) at E11.5. The
r-coded boxes in panels A1–C1 denote areas shown at a higher magnification in
note abnormal chondrocyte morphology; asterisks in panels B2 and C2 indicate
as indicated directly above the panels. Signal is in red and counterstain in blue.
d contours in panels A6–A7, B6–B7 and C6–C7 demarcate equivalent areas in
ression; green arrowheads in panels A6–C6 denote signal in perichondrium.
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Remarkably, in the TM-induced Col2-CreTM; Smon/c embryos,
areas devoid of Ptch1 within the periarticular domain showed
little to no expression of PTHrP (red contour, Figs. 8B6, B7),
whereas the adjacent domains maintaining low levels of Ptch1
also retained PTHrP expression (purple contour, Figs. 8B6,
B7). Importantly, in embryos where Ptch1 expression was not
disturbed in the periarticular area but severely reduced in other
domains of the growth region, PTHrP expression was not
disrupted (green contour, Figs. 8C6, C7). In fact, the PTHrP-
expressing domain appeared to be expanded in these embryos
(Fig. 8, compare A7 and C7), perhaps reflecting further Ihh
movement into the periarticular territory (competent to express
PTHrP) due to the decrease in sequestration by Ptch1 (Chen and
Struhl, 1996). Thus, PTHrP expression by periarticular chon-
drocytes correlated with their own responsiveness to Ihh, but
not with that in the perichondrium or other parts of the growth
region.
We next examined whether localized removal of Smo affect-
ed the morphology of growth plate chondrocytes in the TM-
induced Col2-CreTM; Smon/c embryos. Histology of the hu-
merus revealed obvious anomalies within subdomains of the
growth region in the mutant embryo. In particular, certain flat
chondrocytes (Fig. 8A2) were replaced with cells with hetero-
geneous morphology (red arrows) and irregular spacing
(asterisks) in the mutant sample (Figs. 8B2, C2). The abnormal
morphology could not be accounted for by overt acceleration of
chondrocyte maturation as no ectopic expression of Ihh (Figs.
7B5, C5) or PTHrP-R (data not shown) was detected, and
Colα1(X)was only weakly detectable in a scattered subset of the
affected cells with no correlation with the size of the cell
(orange arrows, Figs. 8B4, C4, data not shown). Importantly,
the anomaly was found exclusively within areas devoid of
Ptch1 expression (asterisks, Figs. 8B6, C6), whereas adjacent
regions that maintained Ptch1 expression were not affected
(Figs. 8B3, C3). Thus, removal of Ihh responsiveness from
subsets of cells within the growth region locally disrupted the
morphology and organization of immature chondrocytes. In
summary, these results support the notion that Ihh directly
controls both PTHrP expression and chondrocyte morphology
in the growth region cartilage.
Discussion
We have described a TM-inducible Col2-CreTM line that can
be used to selectively activate Cre in chondrocytes, overcoming
a limitation of current Col2-Cre transgenic lines that express
Cre in both chondrocytes and the perichondrium (Long et al.,
2004; Sakai et al., 2001). Serendipitously, we found that the
new line also targets a subset of cells associated with the trabe-
cular bone surface, likely reflecting the endogenous activity of
the Colα1(II) promoter that directs expression of the prechon-
drogenic Colα1(II)A isoform in these cells. Finally, utilization
of the Col2-CreTM line in localized removal of Smo has pro-
vided evidence that direct Ihh input is likely required for both
PTHrP expression in the periarticular chondrocytes and the
proper morphology of columnar chondrocytes.The versatility of the Col2-CreTM line lies in the fact that
both cell type selectivity (chondrocytes vs. perichondrial cells)
and localized activity (subsets of chondrocytes) can be achieved
by adjusting the timing or dosage of TM administration. It
should be noted however, that although a higher TM dosage
generally correlated with more cells expressing Cre activity,
certain variability has been observed among embryos from
pregnant females receiving the same amount of TM. In addition,
the location of Cre-active cells within the growth plate also
varied among embryos. These observations reflect a stochastic
aspect of TM-mediated Cre activation, likely resulted from the
variable availability of TM to each cell especially when a lower
dosage was used.
In addition to its utility in embryonic studies, the Col2-CreTM
line also promises to be a useful tool for postnatal genetic
studies. In particular, our results with young pups showed that
nearly all of columnar chondrocytes activated Cre after receiving
two doses of TM. Similarly, a high percentage of the articular
chondrocytes exhibited TM-induced Cre activity. Thus the
Col2-CreTM line may be useful for postnatal studies involving
either the growth plate or the joints.
Several lines of evidence from the present study support that
direct Ihh input is likely required for periarticular chondrocytes
to express PTHrP. First, loss of Ihh response in subsets of
periarticular chondrocytes correlated with the loss of PTHrP in
those cells, whereas cells outside the affected domains main-
tained their normal PTHrP expression profile. Second, loss of
Ihh response in chondrocytes outside the normal PTHrP-
expressing periarticular domain did not diminish PTHrP
expression. Third, Ihh response in the perichondrium did not
correlate with periarticular PTHrP expression. However, the
current data do not exclude the possibility that other signals may
emanate from within the PTHrP-expressing group of cells and
function in either an autocrine or a paracrine manner.
The immediate regulator of PTHrP downstream of Ihh is
presently unknown. In an effort to examine potential direct
regulation of the PTHrP promoter by Ihh, we identified several
putative Gli binding sites approximately 4 kb upstream of the
first exon of the murine PTHrP gene. However, studies of pro-
moter fragments containing these potential sites by transient
transfections in C3H10T1/2 cells have not revealed a consistent
response to exogenous Hh. The most trivial explanation for the
negative results is that the Hh responsive elements were not
included in the tested fragments. However, since PTHrP pro-
moter activity in the embryonic growth plate generally corre-
lates with low- but not high-level Ihh signaling, as indicated by
the low level of Ptch1 in the PTHrP-expressing cells, it is
possible that a “proper” level of Hh signaling required for
activating PTHrP expression was not achieved in the cell
culture model. Finally, Hh may not directly control the promoter
activity of PTHrP. Future studies are required to distinguish
these possibilities.
The present study indicates that direct Ihh input may be
required for the proper morphology of columnar chondrocytes.
Local removal of Ihh responsiveness resulted in abnormal cell
morphology and disorganization of chondrocytes within the
affected regions. Specifically, the number of flat cells was greatly
104 M.J. Hilton et al. / Developmental Biology 308 (2007) 93–105reduced and the normal “stacks” of cells were no longer
evident. The morphological defect was reminiscent to that
observed in Col2-Cre; Smon/c embryos where the entire colum-
nar region was absent (Long et al., 2006), but the underlying
mechanism remains unknown. Ihh could directly control the
cell morphology or, as previously suggested, regulate a
“differentiation” process that encompasses the morphological
changes (Kobayashi et al., 2005). Alternatively, the loss of flat
cells could be secondary to the marked decrease in cell number
within the region in the absence of Ihh signaling (Long et al.,
2001). In any case, the regulation appears to be mediated by
antagonizing Gli3 repressor activity as removal of Gli3 restored
the columnar chondrocytes in the absence of Ihh (Hilton et al.,
2005).
Finally, the current study has identified a Col2-CreTM-
positive cell population primarily associated with the trabecular,
but not the cortical, bone surface. These cells appear to re-
present only a subset of the bone surface cells and are morpho-
logically heterogeneous as appearing on tissue sections. The
role of these cells in vivo remains unknown at present, but they
are capable of producing mineralized bone nodules in vitro.
Molecularly, they do not express high levels of Colα1(I) or Bsp.
However, it should be noted that, in the “co-localization”
experiment, tissue sections were first subjected to Lac Z staining
prior to in situ hybridization for Colα1(I) or Bsp mRNA. Be-
cause we have noticed that the staining procedure notably
reduces the in situ hybridization signals, it is possible that the
Col2-CreTM-positive cells express a lower level of Colα1(I) or
Bsp that is below the current sensitivity threshold. Finally, since
the endogenous Colα1(II) promoter is known to be active in
skeletal precursors during embryogenesis, the Col2-CreTM-
expressing cells may represent a progenitor population uniquely
associated with the trabecular bone both in the embryo and in
postnatal life. Future studies are necessary to determine whether
this is indeed the case.
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